What is the recommended approach for tapering or discontinuing baricitinib therapy in patients with alopecia areata who have achieved remission?

Featuring Karan Lal, DO, MS, FAAD | Director of Pediatric and Cosmetic DermatologyAffiliated DermatologyScottsdale, AZ | Published October 01, 2024